ID THIO_MOUSE Reviewed; 105 AA. AC P10639; Q52KC4; Q9D8R0; DT 01-JUL-1989, integrated into UniProtKB/Swiss-Prot. DT 23-JAN-2007, sequence version 3. DT 02-SEP-2026, entry version 214. DE RecName: Full=Thioredoxin; DE Short=Trx; DE AltName: Full=ATL-derived factor; DE Short=ADF; GN Name=Txn; Synonyms=Txn1; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=2785919; DOI=10.1002/j.1460-2075.1989.tb03436.x; RA Tagaya Y., Maeda Y., Mitsui A., Kndo N., Matsui H., Hamuro J., Brown N., RA Arai K., Yokota T., Wakasugi H., Yodoi J.; RT "ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to RT thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor RT induction."; RL EMBO J. 8:757-764(1989). RN [2] RP ERRATUM OF PUBMED:2785919, AND SEQUENCE REVISION. RX PubMed=8187776; DOI=10.1002/j.1460-2075.1994.tb06502.x; RA Tagaya Y., Maeda Y., Mitsui A., Kndo N., Matsui H., Hamuro J., Brown N., RA Arai K., Yokota T., Wakasugi H., Yodoi J.; RL EMBO J. 13:2244-2244(1994). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=129/Sv; TISSUE=Liver; RX PubMed=7835695; DOI=10.1016/0378-1119(94)00707-y; RA Matsui M., Taniguchi Y., Hirota K., Taketo M., Yodoi J.; RT "Structure of the mouse thioredoxin-encoding gene and its processed RT pseudogene."; RL Gene 152:165-171(1995). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=C57BL/6J; TISSUE=Pancreas; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=C57BL/6J; TISSUE=Colon, and Thymus; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP INTERACTION WITH TXNIP. RX PubMed=10843682; DOI=10.4049/jimmunol.164.12.6287; RA Junn E., Han S.H., Im J.Y., Yang Y., Cho E.W., Um H.D., Kim D.K., Lee K.W., RA Han P.L., Rhee S.G., Choi I.; RT "Vitamin D3 up-regulated protein 1 mediates oxidative stress via RT suppressing the thioredoxin function."; RL J. Immunol. 164:6287-6295(2000). RN [7] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, RC Pancreas, Spleen, and Testis; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [8] RP ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-39 AND LYS-94, SUCCINYLATION RP [LARGE SCALE ANALYSIS] AT LYS-8 AND LYS-94, AND IDENTIFICATION BY MASS RP SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Embryonic fibroblast, and Liver; RX PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001; RA Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y., RA Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.; RT "SIRT5-mediated lysine desuccinylation impacts diverse metabolic RT pathways."; RL Mol. Cell 50:919-930(2013). CC -!- FUNCTION: Participates in various redox reactions through the CC reversible oxidation of its active center dithiol to a disulfide and CC catalyzes dithiol-disulfide exchange reactions (By similarity). Plays a CC role in the reversible S-nitrosylation of cysteine residues in target CC proteins, and thereby contributes to the response to intracellular CC nitric oxide. Nitrosylates the active site Cys of CASP3 in response to CC nitric oxide (NO), and thereby inhibits caspase-3 activity. Induces the CC FOS/JUN AP-1 DNA binding activity in ionizing radiation (IR) cells CC through its oxidation/reduction status and stimulates AP-1 CC transcriptional activity (By similarity). {ECO:0000250}. CC -!- FUNCTION: ADF augments the expression of the interleukin-2 receptor TAC CC (IL2R/P55). CC -!- SUBUNIT: Homodimer; disulfide-linked. Interacts with TXNIP through the CC redox-active site. Interacts with MAP3K5 and CASP3. Interacts with CC APEX1; the interaction stimulates the FOS/JUN AP-1 DNA-binding activity CC in a redox-dependent manner (By similarity). {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P10599}. Cytoplasm CC {ECO:0000250|UniProtKB:P10599}. Secreted CC {ECO:0000250|UniProtKB:P10599}. Note=Translocates from the cytoplasm CC into the nucleus after phorbol 12-myristate 13-acetate induction (PMA). CC Predominantly in the cytoplasm in non irradiated cells. Radiation CC induces translocation of TRX from the cytoplasm to the nucleus. CC Secreted by a leaderless secretory pathway. CC {ECO:0000250|UniProtKB:P10599}. CC -!- PTM: In the fully reduced protein, both Cys-69 and Cys-73 are CC nitrosylated in response to nitric oxide (NO). When two disulfide bonds CC are present in the protein, only Cys-73 is nitrosylated. Cys-73 can CC serve as donor for nitrosylation of target proteins (By similarity). CC {ECO:0000250}. CC -!- SIMILARITY: Belongs to the thioredoxin family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X77585; CAA54688.1; -; mRNA. DR EMBL; D21859; BAA04881.1; -; Genomic_DNA. DR EMBL; AK007537; BAB25096.1; -; mRNA. DR EMBL; AK007790; BAB25256.1; -; mRNA. DR EMBL; BC010756; AAH10756.1; -; mRNA. DR EMBL; BC094415; AAH94415.1; -; mRNA. DR CCDS; CCDS18207.1; -. DR PIR; JC4068; S04107. DR RefSeq; NP_035790.1; NM_011660.3. DR AlphaFoldDB; P10639; -. DR SMR; P10639; -. DR BioGRID; 204389; 39. DR FunCoup; P10639; 1766. DR IntAct; P10639; 3. DR MINT; P10639; -. DR STRING; 10090.ENSMUSP00000030051; -. DR ChEMBL; CHEMBL6067621; -. DR GlyGen; P10639; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; P10639; -. DR PhosphoSitePlus; P10639; -. DR SwissPalm; P10639; -. DR CPTAC; non-CPTAC-3884; -. DR jPOST; P10639; -. DR PaxDb; 10090-ENSMUSP00000030051; -. DR PeptideAtlas; P10639; -. DR ProteomicsDB; 262978; -. DR Pumba; P10639; -. DR TopDownProteomics; P10639; -. DR Antibodypedia; 3281; 868 antibodies from 43 providers. DR DNASU; 22166; -. DR Ensembl; ENSMUST00000030051.6; ENSMUSP00000030051.6; ENSMUSG00000028367.6. DR GeneID; 22166; -. DR KEGG; mmu:22166; -. DR UCSC; uc008syp.1; mouse. DR AGR; MGI:98874; -. DR CTD; 22166; -. DR MGI; MGI:98874; Txn1. DR VEuPathDB; HostDB:ENSMUSG00000028367; -. DR eggNOG; KOG0907; Eukaryota. DR GeneTree; ENSGT00940000154259; -. DR HOGENOM; CLU_090389_14_6_1; -. DR InParanoid; P10639; -. DR OMA; KQLWRQS; -. DR OrthoDB; 2121326at2759; -. DR PhylomeDB; P10639; -. DR Reactome; R-MMU-2559580; Oxidative Stress Induced Senescence. DR Reactome; R-MMU-3299685; Detoxification of Reactive Oxygen Species. DR Reactome; R-MMU-499943; Interconversion of nucleotide di- and triphosphates. DR Reactome; R-MMU-5628897; TP53 Regulates Metabolic Genes. DR Reactome; R-MMU-5676934; Protein repair. DR Reactome; R-MMU-844456; The NLRP3 inflammasome. DR BioGRID-ORCS; 22166; 27 hits in 79 CRISPR screens. DR PRO; PR:P10639; -. DR Proteomes; UP000000589; Chromosome 4. DR RNAct; P10639; protein. DR Bgee; ENSMUSG00000028367; Expressed in jejunum and 71 other cell types or tissues. DR GO; GO:0030424; C:axon; ISO:GO_Central. DR GO; GO:0005737; C:cytoplasm; IDA:MGI. DR GO; GO:0005829; C:cytosol; IDA:MGI. DR GO; GO:0030425; C:dendrite; ISO:GO_Central. DR GO; GO:0005576; C:extracellular region; ISO:GO_Central. DR GO; GO:0005739; C:mitochondrion; HDA:MGI. DR GO; GO:0043025; C:neuronal cell body; ISO:GO_Central. DR GO; GO:0005654; C:nucleoplasm; ISO:GO_Central. DR GO; GO:0005634; C:nucleus; IDA:MGI. DR GO; GO:0019899; F:enzyme binding; ISO:GO_Central. DR GO; GO:0042803; F:protein homodimerization activity; ISO:GO_Central. DR GO; GO:0047134; F:protein-disulfide reductase [NAD(P)H] activity; ISO:GO_Central. DR GO; GO:0015035; F:protein-disulfide reductase activity; IDA:MGI. DR GO; GO:0045454; P:cell redox homeostasis; IDA:MGI. DR GO; GO:0061692; P:cellular detoxification of hydrogen peroxide; ISO:GO_Central. DR GO; GO:0046826; P:negative regulation of protein export from nucleus; IDA:MGI. DR GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IGI:MGI. DR GO; GO:0043388; P:positive regulation of DNA binding; ISS:UniProtKB. DR GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:GO_Central. DR GO; GO:0071731; P:response to nitric oxide; ISO:GO_Central. DR GO; GO:0009314; P:response to radiation; ISS:UniProtKB. DR CDD; cd02947; TRX_family; 1. DR FunFam; 3.40.30.10:FF:000130; Thioredoxin; 1. DR Gene3D; 3.40.30.10; Glutaredoxin; 1. DR InterPro; IPR005746; Thioredoxin. DR InterPro; IPR036249; Thioredoxin-like_sf. DR InterPro; IPR017937; Thioredoxin_CS. DR InterPro; IPR013766; Thioredoxin_domain. DR PANTHER; PTHR46115; THIOREDOXIN-LIKE PROTEIN 1; 1. DR Pfam; PF00085; Thioredoxin; 1. DR PIRSF; PIRSF000077; Thioredoxin; 1. DR PRINTS; PR00421; THIOREDOXIN. DR SUPFAM; SSF52833; Thioredoxin-like; 1. DR PROSITE; PS00194; THIOREDOXIN_1; 1. DR PROSITE; PS51352; THIOREDOXIN_2; 1. PE 1: Evidence at protein level; KW Acetylation; Activator; Cytoplasm; Disulfide bond; Electron transport; KW Nucleus; Redox-active center; Reference proteome; S-nitrosylation; KW Secreted; Transcription; Transcription regulation; Transport. FT CHAIN 1..105 FT /note="Thioredoxin" FT /id="PRO_0000120007" FT DOMAIN 2..105 FT /note="Thioredoxin" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00691" FT ACT_SITE 32 FT /note="Nucleophile" FT /evidence="ECO:0000250" FT ACT_SITE 35 FT /note="Nucleophile" FT /evidence="ECO:0000250" FT SITE 26 FT /note="Deprotonates C-terminal active site Cys" FT /evidence="ECO:0000250" FT SITE 33 FT /note="Contributes to redox potential value" FT /evidence="ECO:0000250" FT SITE 34 FT /note="Contributes to redox potential value" FT /evidence="ECO:0000250" FT MOD_RES 3 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P10599" FT MOD_RES 8 FT /note="N6-succinyllysine" FT /evidence="ECO:0007744|PubMed:23806337" FT MOD_RES 39 FT /note="N6-acetyllysine" FT /evidence="ECO:0007744|PubMed:23806337" FT MOD_RES 62 FT /note="S-nitrosocysteine" FT /evidence="ECO:0000250|UniProtKB:P10599" FT MOD_RES 69 FT /note="S-nitrosocysteine" FT /evidence="ECO:0000250|UniProtKB:P10599" FT MOD_RES 73 FT /note="S-nitrosocysteine; alternate" FT /evidence="ECO:0000250|UniProtKB:P10599" FT MOD_RES 94 FT /note="N6-acetyllysine; alternate" FT /evidence="ECO:0007744|PubMed:23806337" FT MOD_RES 94 FT /note="N6-succinyllysine; alternate" FT /evidence="ECO:0007744|PubMed:23806337" FT DISULFID 32..35 FT /note="Redox-active" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00691" FT DISULFID 73 FT /note="Interchain; alternate" FT /evidence="ECO:0000250" FT CONFLICT 100 FT /note="S -> C (in Ref. 4; BAB25256)" FT /evidence="ECO:0000305" SQ SEQUENCE 105 AA; 11675 MW; 3A2B925935F952DA CRC64; MVKLIESKEA FQEALAAAGD KLVVVDFSAT WCGPCKMIKP FFHSLCDKYS NVVFLEVDVD DCQDVAADCE VKCMPTFQFY KKGQKVGEFS GANKEKLEAS ITEYA //